Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering Analysis.
暂无分享,去创建一个
J. Deux | E. Audureau | E. Itti | T. Damy | V. Audard | F. Le Bras | M. Kharoubi | V. Molinier-Frenkel | P. Fanen | E. Poullot | S. Oghina | M. Bézard | L. Bonnefous | E. Poullot
[1] C. Rapezzi,et al. Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner , 2020, BMC Family Practice.
[2] A. Dispenzieri,et al. Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review. , 2020, JAMA.
[3] M. Maurer,et al. DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis , 2020, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[4] C. Rapezzi,et al. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. , 2019, Circulation. Heart failure.
[5] J. Butler,et al. Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week. , 2019, Journal of the American College of Cardiology.
[6] M. Hanna,et al. Carpal Tunnel Syndrome: A Potential Early, Red-Flag Sign of Amyloidosis. , 2019, The Journal of hand surgery.
[7] R. Falk,et al. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice. , 2019, JACC. Heart failure.
[8] É. Béquignon,et al. Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study , 2019, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[9] C. Rapezzi,et al. Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS) , 2019, European heart journal.
[10] D. Phelan,et al. Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release. , 2018, Journal of the American College of Cardiology.
[11] Song Gao,et al. Numero: a statistical framework to define multivariable subgroups in complex population-based datasets. , 2018, International journal of epidemiology.
[12] V. Aboyans,et al. Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis , 2017, Clinical Research in Cardiology.
[13] É. Béquignon,et al. How your ears can tell what is hidden in your heart: wild-type transthyretin amyloidosis as potential cause of sensorineural hearing loss inelderly-AmyloDEAFNESS pilot study , 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[14] J. Deux,et al. Identification of prognostic markers in transthyretin and AL cardiac amyloidosis* , 2016, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[15] A. Hagège,et al. Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness. , 2016, European heart journal.
[16] C. Rapezzi,et al. Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy , 2016, Open Heart.
[17] E. González-López,et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. , 2015, European heart journal.
[18] F. Rutten,et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.
[19] B. Khandheria,et al. The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease. , 2014, European heart journal cardiovascular Imaging.
[20] Glenn Fung,et al. Personalized cardiovascular medicine: concepts and methodological considerations , 2013, Nature Reviews Cardiology.
[21] Aman Sharma,et al. Skin Involvement in Primary Systemic Amyloidosis , 2013, Mediterranean journal of hematology and infectious diseases.
[22] J. Seward,et al. Infiltrative cardiovascular diseases: cardiomyopathies that look alike. , 2010, Journal of the American College of Cardiology.
[23] Terry M Therneau,et al. Prevalence of monoclonal gammopathy of undetermined significance. , 2006, The New England journal of medicine.
[24] T. Therneau,et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] Giampaolo Merlini,et al. Molecular mechanisms of amyloidosis. , 2003, The New England journal of medicine.
[26] Panu Somervuo,et al. How to make large self-organizing maps for nonvectorial data , 2002, Neural Networks.
[27] Adrian E. Raftery,et al. Model-Based Clustering, Discriminant Analysis, and Density Estimation , 2002 .
[28] J. Kelly,et al. Mechanisms of amyloidogenesis , 2000, Nature Structural Biology.
[29] P. Dyck,et al. The natural history of peripheral neuropathy in primary systemic amyloidosis , 1979, Annals of neurology.
[30] J. Buxbaum,et al. The genetics of the amyloidoses. , 2000, Annual review of medicine.